A Drug Access Navigator (DAN) is a role that has been established in patient care settings with the goal of expediting the process by which patients obtain drugs through the Health Canada Special Access Program (SAP), individual drug companies’ patient access programs (PAP), and public and private drug plans. In the paediatric setting, the process of accessing many drugs has grown increasingly complex. The majority of paediatric prescriptions involve ‘off-label’ drug use. This leads to an increased need for drug access through the SAP and/or PAPs and demonstrates that the need for a DAN may be particularly prominent in the paediatric population. To our knowledge, there is no evidence in the literature of a DAN functioning in a paediatric setting, though there is a demonstrable need. We plan to address this need by introducing a DAN for shared use at BC Children’s Hospital, a paediatric tertiary care centre.

中文翻译：

---

在儿科护理中探索药物获取的复杂领域

药物获取导航员 (DAN) 是在患者护理环境中建立的角色，其目标是加快患者通过加拿大卫生部特殊获取计划 (SAP)、个别制药公司的患者获取计划 (PAP) 获取药物的过程)，以及公共和私人药物计划。在儿科环境中，获取多种药物的过程变得越来越复杂。大多数儿科处方都涉及“标签外”药物使用。这导致通过 SAP 和/或 PAP 获取药物的需求增加，并表明对 DAN 的需求可能在儿科人群中尤为突出。据我们所知，文献中没有证据表明 DAN 在儿科环境中发挥作用，尽管有明显的需求。